138 related articles for article (PubMed ID: 20390465)
1. Medullary carcinoma of the breast: a population-based perspective.
Martinez SR; Beal SH; Canter RJ; Chen SL; Khatri VP; Bold RJ
Med Oncol; 2011 Sep; 28(3):738-44. PubMed ID: 20390465
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
Leggett MD; Chen SL; Schneider PD; Martinez SR
Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
[TBL] [Abstract][Full Text] [Related]
3. Competing Risk Analyses of Medullary Carcinoma of Breast in Comparison to Infiltrating Ductal Carcinoma.
Dai D; Shi R; Wang Z; Zhong Y; Shin VY; Jin H; Wang X
Sci Rep; 2020 Jan; 10(1):560. PubMed ID: 31953417
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant external beam radiation for medullary thyroid carcinoma.
Martinez SR; Beal SH; Chen A; Chen SL; Schneider PD
J Surg Oncol; 2010 Aug; 102(2):175-8. PubMed ID: 20648590
[TBL] [Abstract][Full Text] [Related]
5. Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma: a population based study from SEER 18 database.
Wang XX; Jiang YZ; Liu XY; Li JJ; Song CG; Shao ZM
Oncotarget; 2016 Apr; 7(16):22665-73. PubMed ID: 27009810
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma.
Beal SH; Chen SL; Schneider PD; Martinez SR
Am Surg; 2010 Jan; 76(1):28-32. PubMed ID: 20135936
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy could benefit early-stage ER/PR positive mucinous breast cancer: A SEER-based analysis.
Gao HF; Li WP; Zhu T; Yang CQ; Yang M; Zhang LL; Ji F; Cheng MY; Li JQ; Wang K
Breast; 2020 Dec; 54():79-87. PubMed ID: 32947149
[TBL] [Abstract][Full Text] [Related]
8. Potential roles of lymphovascular space invasion based on tumor characteristics provide important prognostic information in T1 tumors with ER and HER2 positive breast cancer.
Zhao Y; Yang N; Wang X; Huang Y; Zhou X; Zhang D
Clin Transl Oncol; 2020 Dec; 22(12):2275-2285. PubMed ID: 32447641
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
Lai HW; Tseng LM; Chang TW; Kuo YL; Hsieh CM; Chen ST; Kuo SJ; Su CC; Chen DR
Breast; 2013 Oct; 22(5):968-73. PubMed ID: 23787124
[TBL] [Abstract][Full Text] [Related]
10. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
13. Invasive micropapillary carcinoma of the breast has a better long-term survival than invasive ductal carcinoma of the breast in spite of its aggressive clinical presentations: a comparison based on large population database and case-control analysis.
Chen H; Wu K; Wang M; Wang F; Zhang M; Zhang P
Cancer Med; 2017 Dec; 6(12):2775-2786. PubMed ID: 29072365
[TBL] [Abstract][Full Text] [Related]
14. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study.
Wei JL; Zhang JX; Fu DY
World J Surg Oncol; 2018 Dec; 16(1):236. PubMed ID: 30558615
[TBL] [Abstract][Full Text] [Related]
15. Lymph node yield as a predictor of overall survival following inguinal lymphadenectomy for penile cancer.
Soodana-Prakash N; Koru-Sengul T; Miao F; Lopategui DM; Savio LF; Moore KJ; Johnson TA; Alameddine M; Barboza MP; Parekh DJ; Punnen S; Gonzalgo ML; Ritch CR
Urol Oncol; 2018 Oct; 36(10):471.e19-471.e27. PubMed ID: 30143385
[TBL] [Abstract][Full Text] [Related]
16. Survival in 12,653 breast cancer patients with extensive axillary lymph node metastasis in the anthracycline era.
Beal SH; Martinez SR; Canter RJ; Chen SL; Khatri VP; Bold RJ
Med Oncol; 2010 Dec; 27(4):1420-4. PubMed ID: 20049562
[TBL] [Abstract][Full Text] [Related]
17. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
[TBL] [Abstract][Full Text] [Related]
18. Prognostic markers for invasive micropapillary carcinoma of the breast: a population-based analysis.
Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
Clin Breast Cancer; 2013 Apr; 13(2):133-9. PubMed ID: 23246269
[TBL] [Abstract][Full Text] [Related]
19. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer.
Rose BS; Jiang W; Punglia RS
Breast Cancer Res Treat; 2015 Jul; 152(1):209-216. PubMed ID: 26041688
[TBL] [Abstract][Full Text] [Related]
20. Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.
Kroeger N; Pantuck AJ; Wells JC; Lawrence N; Broom R; Kim JJ; Srinivas S; Yim J; Bjarnason GA; Templeton A; Knox J; Bernstein E; Smoragiewicz M; Lee J; Rini BI; Vaishampayan UN; Wood LA; Beuselinck B; Donskov F; Choueiri TK; Heng DY
Eur Urol; 2015 Sep; 68(3):506-15. PubMed ID: 25524810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
